Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 July 2020 | Story Nitha Ramnath | Photo UFS photo archive

The Department of Business Management within the Faculty of Economic and Management Sciences is one of four successful recipients of the Nurturing Emerging Scholars Programme (NESP), which aims to recruit honours graduates who demonstrate academic ability and express an early interest in the possibility of an academic career. 

 “The NESP is a mechanism that addresses a potential shortcoming in the department in the medium to long term. Most of the academics in the department specialise either in entrepreneurship or marketing. As such, the availability of academics with interdisciplinary business knowledge who can teach and do research across the different sub-fields of business management is limited,” says Prof Brownhilder Neneh, Associate Professor in the Department of Business Management.

Once graduates enter the programme – as NESP master’s graduates they form part of a resource pool from which new academics can be recruited. 

Prof Neneh continues: “Considering the imminent retirement of academics in the department, the NESP provides an opportunity to recruit an academic who is able to work with experienced academics, gain experience, and ‘prepare’ the person to become an expert across the different fields in the department.”

“This programme would assist in succession planning within the department as well as training individuals within academia,” she says. 

According to Prof Neneh, access to this funding opportunity will further strengthen and expand the path that the department has embarked upon as far as striving for excellence in teaching, research, and community engagement is concerned, thereby contributing to address key societal challenges. “Appointing an NESP candidate would be an ideal opportunity to recruit an academic who will be able to work with the senior staff and gain experience and teaching/research competencies relevant to the 4IR, and ‘prepare’ the person to become the business management expert in the department,” she says.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept